Home / Healthcare/ Dengue early detection kit ‘CareStart’ hits market

Dengue early detection kit ‘CareStart’ hits market


Comments / {{hitsCtrl.values.hits}} Views / Tuesday, 17 July 2018 00:00


 

By Ruwandi Gamage

A qualitative rapid diagnostic kit designed for early diagnosis to help lower the risk of mortality and medical complications for dengue was introduced to the market. 

This FDA-approved dengue combo kit will retail at a price of Rs. 1,500 for patients and can only be obtained through GPs in your area, as it is recommended that a medical professional should administer the test. 

Dr. Han representing Access Bio introduced the kit to the audience and explained why it was the best diagnostic test in the market for dengue. 

“The sensitivity of this test is the best developed in the world and we vouch for 95% accuracy. Therefore, it can distinguish between primary and secondary dengue infection. This combo kit is more useful for the early diagnosis of dengue sequels such as Dengue Haemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS),” he said.

The test is introduced to the Sri Lankan market by Mega Pharma Ltd., a pharmaceutical company which promotes innovative medical devices, in collaboration with Access Bio, USA, a bio-tech company dedicated to the prevention and early diagnosis of infectious diseases through research, development, and manufacturing of diagnostic tests and products.

Mega Pharma Chairman and Managing Director Shirantha Peiris explained to Daily FT that he partnered up with a friend in US to bring this kit to Sri Lanka and it took the company two years to obtain approval for its sale here.

Addressing the invitees and media, Peiris outlined the retail prices and further plans of distribution.

“The kit will be available for Rs. 1,000 for the doctors and we recommend a retail price of Rs. 1,500 to the patients. We are hoping to collaborate and introduce this kit to hospitals for better reach. From Monday (16) onwards the product will be accessible to doctors via our teams,” he said.

The ‘CareStart’ dengue combo kit was launched on 13 July at Waters Edge, Battaramulla.

Pix by Waruna Wanniarachchi 


Share This Article


DISCLAIMER:

1. All comments will be moderated by the Daily FT Web Editor.

2. Comments that are abusive, obscene, incendiary, defamatory or irrelevant will not be published.

3. We may remove hyperlinks within comments.

4. Kindly use a genuine email ID and provide your name.

5. Spamming the comments section under different user names may result in being blacklisted.

COMMENTS

Today's Columnists

Reaching global quality standards through Deming Award

Wednesday, 21 November 2018

The importance of quality in the contemporary competitive business environment cannot be over-emphasised. Total Quality Management (TQM)is a company-wide, all pervasive management philosophy, which organisations globally, in many business sectors hav


Ramsar accreditation of Colombo Wetlands: Rebranding Colombo as a Wetland City

Wednesday, 21 November 2018

Colombo, once known to be “kolonthota,” has always been identified as a wetland complex at the heart of the Kelani river delta. Today this city is increasingly drying up, with around 20 sq km left as wetlands which continue to be threatened every


Coup Sri Lanka: some winners, mostly losers

Wednesday, 21 November 2018

As a president proves shockingly stubborn, a nation waits with baited breath as to what His Excellency the loose cannon on a rocky slope will do next. Two Prime Ministers and the fates of their respective parliamentary groups hang in the balance lik


Rising dollar and bank NPA, brothers in arms?

Wednesday, 21 November 2018

The rising Non-Performing Advances (NPA/NPAs) is a matter of concern to the entire financial industry. It is a nightmare. The weekend papers have published some articles based on interviews journalists conducted with respective bank CEOs and also bas


Columnists More